# TOFACITINIB CITRATE
> **ANDA216878** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-09-25
## Drug
- **FDA Application Number:** ANDA216878
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOFACITINIB CITRATE
- **Generic name:** Tofacitinib Citrate
- **Active ingredients:** TOFACITINIB CITRATE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** HIKMA
- **First approval:** 2023-09-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216878)
---
*AI Analytics · CC0 1.0*